SubjectWell Announces Matthias Roos as New Director of Scientific Affairs
As Director of Scientific Affairs, Matthias Roos will lead global research initiatives and thought leadership programs to drive innovation in patient recruitment and clinical development.
Ensuring diversity in a Large Type II diabetes study
SubjectWell’s targeted recruitment strategy ensured a diverse and representative patient population for a large Type 2 diabetes study, surpassing diversity goals for patients over 65 and increasing Black patient enrollment beyond expectations.
New FMLA Guidance Empowers Patients to Participate in Clinical Trials
New FMLA guidance now protects job security for patients participating in clinical trials, removing a major barrier to accessing innovative treatments.
SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities
Austin, TX, September 17, 2024 — SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies. The integration of […]
How Medical Contact Centers Power Patient Recruitment for Clinical Trials
Patient recruitment is one of the most critical and challenging aspects of clinical trials. Medical contact centers can be beneficial to the entire healthcare industry, but we’re going to focus on how they can help clinical trial participation. These contact centers drive study enrollment by improving the patient recruitment process through patient engagement and education. […]
3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments.
Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs. […]
WindRose Health Investors Completes Majority Growth Investment in SubjectWell
New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision […]
SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification
The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment. AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which […]
SubjectWell Acquires PatientCentra
Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers […]
